Discussion on “Surrogate Measures and Consistent Surrogates”
Author
Abstract
Suggested Citation
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Peter B. Gilbert & Michael G. Hudgens, 2008. "Evaluating Candidate Principal Surrogate Endpoints," Biometrics, The International Biometric Society, vol. 64(4), pages 1146-1154, December.
- Constantine E. Frangakis & Donald B. Rubin, 2002. "Principal Stratification in Causal Inference," Biometrics, The International Biometric Society, vol. 58(1), pages 21-29, March.
- Zelterman, Daniel, 1990. "On tests for qualitative interactions," Statistics & Probability Letters, Elsevier, vol. 10(1), pages 59-63, June.
- Gustafson Paul, 2010. "Bayesian Inference for Partially Identified Models," The International Journal of Biostatistics, De Gruyter, vol. 6(2), pages 1-20, March.
- Yun Li & Jeremy M.G. Taylor & Michael R. Elliott, 2010. "A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials," Biometrics, The International Biometric Society, vol. 66(2), pages 523-531, June.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Ying Huang & Shibasish Dasgupta, 2019. "Likelihood-Based Methods for Assessing Principal Surrogate Endpoints in Vaccine Trials," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 11(3), pages 504-523, December.
- Corwin M. Zigler & Thomas R. Belin, 2012. "A Bayesian Approach to Improved Estimation of Causal Effect Predictiveness for a Principal Surrogate Endpoint," Biometrics, The International Biometric Society, vol. 68(3), pages 922-932, September.
- Gilbert Peter B. & Blette Bryan S. & Hudgens Michael G. & Shepherd Bryan E., 2020. "Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial," Journal of Causal Inference, De Gruyter, vol. 8(1), pages 54-69, January.
- Ying Huang & Peter B. Gilbert & Julian Wolfson, 2013. "Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials," Biometrics, The International Biometric Society, vol. 69(2), pages 301-309, June.
- Zhichao Jiang & Shu Yang & Peng Ding, 2022. "Multiply robust estimation of causal effects under principal ignorability," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 84(4), pages 1423-1445, September.
- Gilbert Peter B. & Blette Bryan S. & Shepherd Bryan E. & Hudgens Michael G., 2020. "Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial," Journal of Causal Inference, De Gruyter, vol. 8(1), pages 54-69, January.
- Ariel Alonso & Wim Van der Elst & Geert Molenberghs & Marc Buyse & Tomasz Burzykowski, 2015. "On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints," Biometrics, The International Biometric Society, vol. 71(1), pages 15-24, March.
- Ying Huang & Peter B. Gilbert, 2011. "Comparing Biomarkers as Principal Surrogate Endpoints," Biometrics, The International Biometric Society, vol. 67(4), pages 1442-1451, December.
- Laura Forastiere & Patrizia Lattarulo & Marco Mariani & Fabrizia Mealli & Laura Razzolini, 2021.
"Exploring Encouragement, Treatment, and Spillover Effects Using Principal Stratification, With Application to a Field Experiment on Teens’ Museum Attendance,"
Journal of Business & Economic Statistics, Taylor & Francis Journals, vol. 39(1), pages 244-258, January.
- Laura Forastiere & Patrizia Lattarulo & Marco Mariani & Fabrizia Mealli & Laura Razzolini, 2019. "Exploring encouragement, treatment and spillover effects using principal stratification, with application to a field experiment on teens' museum attendance," Natural Field Experiments 00673, The Field Experiments Website.
- Debashis Ghosh & Jeremy M. G. Taylor & Daniel J. Sargent, 2012. "Rejoinder for “Meta-analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling”," Biometrics, The International Biometric Society, vol. 68(1), pages 245-247, March.
- Li He & Yu-Bo Wang & William C. Bridges & Zhulin He & S. Megan Che, 2023. "Bayesian Framework for Causal Inference with Principal Stratification and Clusters," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 15(1), pages 114-140, April.
- Ghosh, Debashis, 2012. "A causal framework for surrogate endpoints with semi-competing risks data," Statistics & Probability Letters, Elsevier, vol. 82(11), pages 1898-1902.
- Silvia Noirjean & Mario Biggeri & Laura Forastiere & Fabrizia Mealli & Maria Nannini, 2023. "Estimating causal effects of community health financing via principal stratification," Statistical Methods & Applications, Springer;Società Italiana di Statistica, vol. 32(4), pages 1317-1350, October.
- Tyler J. VanderWeele, 2013. "Surrogate Measures and Consistent Surrogates," Biometrics, The International Biometric Society, vol. 69(3), pages 561-565, September.
- VanderWeele Tyler J, 2011. "Principal Stratification -- Uses and Limitations," The International Journal of Biostatistics, De Gruyter, vol. 7(1), pages 1-14, July.
- Tyler J. VanderWeele, 2013. "Rejoinder," Biometrics, The International Biometric Society, vol. 69(3), pages 577-581, September.
- Patrick M. Schnell & Richard Baumgartner & Shahrul Mt‐Isa & Vladimir Svetnik, 2022. "A principal stratification approach to estimating the effect of continuing treatment after observing early outcomes," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 71(5), pages 1065-1084, November.
- Gilbert Peter B. & Hudgens Michael G. & Wolfson Julian, 2011. "Commentary on "Principal Stratification -- a Goal or a Tool?" by Judea Pearl," The International Journal of Biostatistics, De Gruyter, vol. 7(1), pages 1-15, September.
- Gilbert Peter B. & Gabriel Erin E. & Huang Ying & Chan Ivan S.F., 2015. "Surrogate Endpoint Evaluation: Principal Stratification Criteria and the Prentice Definition," Journal of Causal Inference, De Gruyter, vol. 3(2), pages 157-175, September.
- Julian Wolfson & Peter Gilbert, 2010. "Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials," Biometrics, The International Biometric Society, vol. 66(4), pages 1153-1161, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:biomet:v:69:y:2013:i:3:p:565-569. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www.blackwellpublishing.com/journal.asp?ref=0006-341X .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.